content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001550642</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001739426</issuerCik>
        <issuerName>RVL Pharmaceuticals plc</issuerName>
        <secFileNumber>001-38709</secFileNumber>
        <issuerAddress>
          <com:street1>400 CROSSING BOULEVARD</com:street1>
          <com:city>BRIDGEWATER</com:city>
          <com:stateOrCountry>NJ</com:stateOrCountry>
          <com:zipCode>08807</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>9088091300</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Venkataraman Sriram</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Venture Investor/General Partner</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>RVL Pharmaceuticals plc</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Merrill Lynch</name>
          <address>
            <com:street1>555 California St, 18th FL</com:street1>
            <com:city>San Francisco</com:city>
            <com:stateOrCountry>CA</com:stateOrCountry>
            <com:zipCode>94104</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>160078</noOfUnitsSold>
        <aggregateMarketValue>16007.80</aggregateMarketValue>
        <noOfUnitsOutstanding>99535197</noOfUnitsOutstanding>
        <approxSaleDate>08/30/2023</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Ordinary</securitiesClassTitle>
        <acquiredDate>08/08/2022</acquiredDate>
        <natureOfAcquisitionTransaction>Private Placement</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Sriram Venkataraman</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>300845</amountOfSecuritiesAcquired>
        <paymentDate>08/08/2022</paymentDate>
        <natureOfPayment>Private placement</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Sriram Venkataraman</name>
          <address>
            <com:street1>65 E 55th St</com:street1>
            <com:street2>Floor 18</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10022</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Ordinary</securitiesClassTitle>
        <saleDate>08/24/2023</saleDate>
        <amountOfSecuritiesSold>140767</amountOfSecuritiesSold>
        <grossProceeds>17156.43</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>THOD Corp</name>
          <address>
            <com:street1>65 E 55th St</com:street1>
            <com:street2>Floor 18</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10022</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Ordinary</securitiesClassTitle>
        <saleDate>08/24/2023</saleDate>
        <amountOfSecuritiesSold>767515</amountOfSecuritiesSold>
        <grossProceeds>107452.10</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>DAFB Corp</name>
          <address>
            <com:street1>65 E 55th St</com:street1>
            <com:street2>Floor 18</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10022</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Ordinary</securitiesClassTitle>
        <saleDate>08/24/2023</saleDate>
        <amountOfSecuritiesSold>767515</amountOfSecuritiesSold>
        <grossProceeds>107452.10</grossProceeds>
      </securitiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>08/30/2023</noticeDate>
        <signature>Sriram Venkataraman</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4662}]
text: 144
  0001550642
  XXXXXXXX
  LIVE
  0001739426
  RVL Pharmaceuticals plc
  001-38709
  400 CROSSING BOULEVARD
  BRIDGEWATER
  NJ
  08807
  9088091300
  Venkataraman Sriram
  Venture Investor/General Partner
  RVL Pharmaceuticals plc
  Merrill Lynch
  555 California St, 18th FL
  San Francisco
  CA
  94104
  160078
  16007.80
  99535197
  08/30/2023
  NASDAQ
  Ordinary
  08/08/2022
  Private Placement
  Sriram Venkataraman
  N
  300845
  08/08/2022
  Private placement
  N
  Sriram Venkataraman
  65 E 55th St
  Floor 18
  New York
  NY
  10022
  Ordinary
  08/24/2023
  140767
  17156.43
  THOD Corp
  65 E 55th St
  Floor 18
  New York
  NY
  10022
  Ordinary
  08/24/2023
  767515
  107452.10
  DAFB Corp
  65 E 55th St
  Floor 18
  New York
  NY
  10022
  Ordinary
  08/24/2023
  767515
  107452.10
  08/30/2023
  Sriram Venkataraman